Latest filing published 16 Jun 2025 for Sangamo Therapeutics, INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -68.6%Entry US$4.14 · Close at T+365 US$1.30
- +1.6%Entry US$13,160.00 · Close at T+365 US$13,370.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
H. Stewart Parker: trading record in brief
H. Stewart Parker (board member) discloses dealings in 6 companies, chiefly Sangamo Therapeutics, Inc, Armata Pharmaceuticals, Inc. and Impel Neuropharma Inc. The record holds 35 filings, for trades running from 5 September 2006 to 12 June 2025.
On the market, this insider has only ever bought: 9 purchases, €107k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 15 share grants and 5 option exercises.
A typical purchase (the median) is worth €14k. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +191.0%. They describe history only and say nothing certain about the share price ahead.
On 16 June 2025 came the latest disclosure, a share grant in Sangamo Therapeutics, Inc. The most recent open-market purchase was published on 3 June 2022, 1,620 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to H. Stewart Parker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common StockSEC:0001415889-25-017373:0
- 40,983 shares0Common StockSEC:0000905148-25-002131:0
- 30,120 shares0Common StockSEC:0000905148-24-001718:0
- 25,000 shares0Common StockSEC:0001415889-24-015761:0
- 34,602 shares0Common StockSEC:0001610717-23-000159:0
- 13,900 shares0Common StockSEC:0001209191-23-034403:0
- 37,878 shares0Common StockSEC:0001567619-22-021869:0
- 5,000 shares@ US$3.5992100.0% of flowCommon StockSEC:0001209191-22-034036:0Canonical exit: 30 Aug 2022 (T+90)
- 12,500 shares0Common StockSEC:0001209191-22-014149:0
- 271 shares@ US$13.50100.0% of flowCommon StockSEC:0001209191-21-029105:5
- 3,732 sharesCommon StockSEC:0001209191-21-029105:0
- 7,355 sharesCommon StockSEC:0001209191-21-029105:1
- 458 shares0Common StockSEC:0001209191-21-029105:2
- 8,793 sharesCommon StockSEC:0001209191-21-029105:3
- 1,666 shares0Common StockSEC:0001209191-21-029105:4
- 8,200 shares0Common StockSEC:0001209191-21-015510:0
- 10,000 shares0Common StockSEC:0001209191-20-034022:0
- 2,500 shares0Common StockSEC:0001209191-20-030959:0
- 3,000 shares@ US$5.20Common StockSEC:0001209191-20-020353:0Canonical exit: 16 Jun 2020 (T+90)
- 2,500 shares0Common StockSEC:0001209191-19-036441:0
- 2,000 shares@ US$9.00Common StockSEC:0001209191-18-058823:0Canonical exit: 12 Feb 2019 (T+90)
- 2,000 shares@ US$13.52Common StockSEC:0001209191-18-050123:0Canonical exit: 6 Dec 2018 (T+90)
- 2,500 shares0Common StockSEC:0001209191-18-037348:0
- 2,500 sharesCommon StockSEC:0001209191-16-122831:0
- 2,500 sharesCommon StockSEC:0001209191-15-045788:0
25 of 35 declarations
